Completed PHASE3 INTERVENTIONAL 2-arm NCT03280615

Omega 3 Fatty Acids in Patients With Chronic Renal Disease

Effects of the Supplementation With Omega 3 Fatty Acids in Patients With Chronic Renal Disease

Sponsor: Servicio de Salud Metropolitano Oriente

Interventions Corn oil Omega 3 fatty acids

Updated 8 times since 2017 Last updated: Jul 30, 2019 Started: Sep 20, 2017 Primary completion: Oct 31, 2018 Completion: Oct 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Renal Insufficiency, Chronic, this trial is completed. The trial is conducted by Servicio de Salud Metropolitano Oriente and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Oct 2019 — Jan 2021 [monthly]

Completed PHASE3
Feb 2019 — Oct 2019 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 3 earlier versions

Jun 2018 — Feb 2019 [monthly]

Recruiting PHASE3
Nov 2017 — Jun 2018 [monthly]

Recruiting PHASE3
Oct 2017 — Nov 2017 [monthly]

Recruiting PHASE3

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Servicio de Salud Metropolitano Oriente
University of Chile

Data source: University of Chile

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Santiago, Chile